Why is fair value unavailable for Aeolus Pharmaceuticl (OTC-AOLS) stock?

A reliable fair value estimate is not currently available for Aeolus Pharmaceuticl (OTC-AOLS). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

How is the financial health of Aeolus Pharmaceuticl?

The current financial health read for Aeolus Pharmaceuticl (OTC-AOLS) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Does Aeolus Pharmaceuticl (OTC-AOLS) pay dividends?

The latest available data indicates no current dividend yield for Aeolus Pharmaceuticl (OTC-AOLS).

What is the market capitalization of Aeolus Pharmaceuticl?

The current market capitalization listed for Aeolus Pharmaceuticl is 0.152 K.

What is the ticker symbol for Aeolus Pharmaceuticl?

The ticker symbol for Aeolus Pharmaceuticl is OTC-AOLS, and the stock is listed on OTC Markets.

Where is Aeolus Pharmaceuticl (OTC-AOLS) listed?

Aeolus Pharmaceuticl (OTC-AOLS) is listed on OTC Markets.

Aeolus Pharmaceuticl (AOLS) Fair Value & Stock Analysis

Aeolus Pharmaceuticl (AOLS)

Aeolus Pharmaceuticals, Inc. is a U.S.-based biopharmaceutical company focused on developing novel compounds for biodefense and for therapeutic use in fibrosis, oncology, infectious diseases, and central nervous system disorders. The company’s work centers on catalytic antioxidant compounds intended as medical countermeasures against nuclear, radiological, and chemical threats, as well as potential treatments for respiratory, neurological, and cancer-related conditions. Its lead candidate, AEOL 10150, has completed two Phase I clinical trials and is being developed for the pulmonary sub-syndrome of acute radiation syndrome and for exposure to chemical vesicants and nerve agents. Aeolus is also advancing AEOL 11207 as a potential treatment for Parkinson’s disease. The company was founded in 1994 and is based in Mission Viejo, California. Aeolus Pharmaceuticals common stock trades on OTC Markets under the symbol AOLS.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Market Cap
OTC-AOLS	Not available	Not available	Not available	Weak	0.0%	0.152 K